These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10532602)

  • 21. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
    Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
    Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme inhibitors and expression of des-Arg9-BK (kinin B1) receptors in vivo.
    Nwator IA; Whalley ET
    Eur J Pharmacol; 1989 Jan; 160(1):125-32. PubMed ID: 2540986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1.
    deBlois D; Bouthillier J; Marceau F
    Br J Pharmacol; 1991 May; 103(1):1057-66. PubMed ID: 1878745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.
    Prasad A; Husain S; Quyyumi AA
    J Am Coll Cardiol; 1999 Mar; 33(3):796-804. PubMed ID: 10080484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.
    Audet R; Rioux F; Drapeau G; Marceau F
    J Pharmacol Exp Ther; 1997 Jan; 280(1):6-15. PubMed ID: 8996175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.
    Bélichard P; Loillier B; Paquet JL; Luccarini JM; Pruneau D
    Br J Pharmacol; 1996 Apr; 117(7):1565-71. PubMed ID: 8730755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective expression of des-Arg9-BK sensitive (B1) receptors in vivo and in vitro by angiotensin converting enzyme inhibitors.
    Whalley ET; Nwator IA
    Adv Exp Med Biol; 1989; 247A():185-9. PubMed ID: 2557739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
    Stanziola L; Greene LJ; Santos RA
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):1021-9. PubMed ID: 10560789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1951-6. PubMed ID: 3013204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bradykinin production during donor plasmapheresis procedures.
    Perseghin P; Capra M; Baldini V; Sciorelli G
    Vox Sang; 2001 Jul; 81(1):24-8. PubMed ID: 11520412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of a novel molecular assay examining the role of aminopeptidase P polymorphisms in acute hypotensive transfusion reactions.
    Hui Y; Wu Y; Tormey CA
    Arch Pathol Lab Med; 2013 Jan; 137(1):96-9. PubMed ID: 23276181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy.
    Fried MR; Eastlund T; Christie B; Mullin GT; Key NS
    Transfusion; 1996 Oct; 36(10):900-3. PubMed ID: 8863778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hypotensive response induced by des-Arg9-bradykinin in young brown/Norway rats pretreated with endotoxin.
    Tokumasu T; Ueno A; Oh-ishi S
    Eur J Pharmacol; 1995 Feb; 274(1-3):225-8. PubMed ID: 7768275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.
    Molinaro G; Cugno M; Perez M; Lepage Y; Gervais N; Agostoni A; Adam A
    J Pharmacol Exp Ther; 2002 Oct; 303(1):232-7. PubMed ID: 12235256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of hypotension and acute hypotensive transfusion reactions following platelet concentrate transfusions.
    Du Pont-Thibodeau G; Robitaille N; Gauvin F; Thibault L; Rivard GÉ; Lacroix J; Tucci M
    Vox Sang; 2016 Feb; 110(2):150-8. PubMed ID: 26389829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
    Meini S; Lecci A; Maggi CA
    Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bradykinin and des-Arg(9)-bradykinin metabolic pathways and kinetics of activation of human plasma.
    Cyr M; Lepage Y; Blais C; Gervais N; Cugno M; Rouleau JL; Adam A
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H275-83. PubMed ID: 11406494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.